CPC - CERCLE DES PHARMACIENS COOPERATEURS : revenue, balance sheet and financial ratios

CPC - CERCLE DES PHARMACIENS COOPERATEURS is a French company founded 8 years ago, specialized in the sector Autres activités de soutien aux entreprises n.c.a.. Based in CASTELNAU-LE-LEZ (34170), this company of category PME shows in 2019 a revenue of 1.5 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - CPC - CERCLE DES PHARMACIENS COOPERATEURS (SIREN 834933426)
Indicator 2024 2023 2022 2019 2018
Revenue N/C N/C N/C 1 480 342 € 845 413 €
Net income 4 687 095 € 3 094 114 € 1 901 981 € 1 138 931 € 772 193 €
EBITDA N/C N/C N/C 1 204 407 € 801 877 €
Net margin N/C N/C N/C 76.9% 91.3%

Revenue and income statement

In 2024, CPC - CERCLE DES PHARMACIENS COOPERATEURS generates positive net income of 4.7 M€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2024: 772 k€ -> 4.7 M€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

4 687 095 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 80%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.081%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

80.434%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

94.5%

Solvency indicators evolution
CPC - CERCLE DES PHARMACIENS COOPERATEURS

Sector positioning

Debt ratio
0.08 2024
2022
2023
2024
Q1: 0.0
Med: 5.61
Q3: 47.03
Good

In 2024, the debt ratio of CPC - CERCLE DES PHARMACI... (0.08) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
80.43% 2024
2022
2023
2024
Q1: 6.21%
Med: 32.46%
Q3: 67.88%
Excellent

In 2024, the financial autonomy of CPC - CERCLE DES PHARMACI... (80.4%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 449.97. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

449.971

Liquidity indicators evolution
CPC - CERCLE DES PHARMACIENS COOPERATEURS

Sector positioning

Liquidity ratio
449.97 2024
2022
2023
2024
Q1: 120.11
Med: 218.14
Q3: 571.7
Good -9 pts over 3 years

In 2024, the liquidity ratio of CPC - CERCLE DES PHARMACI... (449.97) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
CPC - CERCLE DES PHARMACIENS COOPERATEURS

Positioning of CPC - CERCLE DES PHARMACIENS COOPERATEURS in its sector

Comparison with sector Autres activités de soutien aux entreprises n.c.a.

Valuation estimate

Based on 131 transactions of similar company sales (all years), the value of CPC - CERCLE DES PHARMACIENS COOPERATEURS is estimated at 15 538 705 € (range 4 648 558€ - 45 750 073€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
131 transactions
4648k€ 15538k€ 45750k€
15 538 705 € Range: 4 648 558€ - 45 750 073€
NAF 5 all-time

Valuation method used

Net Income Multiple
4 687 095 € × 3.3x = 15 538 705 €
Range: 4 648 558€ - 45 750 073€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 131 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Autres activités de soutien aux entreprises n.c.a.)

Compare CPC - CERCLE DES PHARMACIENS COOPERATEURS with other companies in the same sector:

Voir toutes les statistiques du secteur Autres activités de soutien aux entreprises n.c.a.

Frequently asked questions about CPC - CERCLE DES PHARMACIENS COOPERATEURS

What is the revenue of CPC - CERCLE DES PHARMACIENS COOPERATEURS ?

The revenue of CPC - CERCLE DES PHARMACIENS COOPERATEURS in 2019 is 1.5 M€.

Is CPC - CERCLE DES PHARMACIENS COOPERATEURS profitable?

Yes, CPC - CERCLE DES PHARMACIENS COOPERATEURS generated a net profit of 4.7 M€ in 2024.

Where is the headquarters of CPC - CERCLE DES PHARMACIENS COOPERATEURS ?

The headquarters of CPC - CERCLE DES PHARMACIENS COOPERATEURS is located in CASTELNAU-LE-LEZ (34170), in the department Herault.

Where to find the tax return of CPC - CERCLE DES PHARMACIENS COOPERATEURS ?

The tax return of CPC - CERCLE DES PHARMACIENS COOPERATEURS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does CPC - CERCLE DES PHARMACIENS COOPERATEURS operate?

CPC - CERCLE DES PHARMACIENS COOPERATEURS operates in the sector Autres activités de soutien aux entreprises n.c.a. (NAF code 82.99Z). See the 'Sector positioning' section above to compare the company with its competitors.